Related Experiment Video

Updated: Jun 11, 2025

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

10.0K

Mex3a Protects Against Atherosclerosis: Evidence From Mice and Humans

Donato Santovito1,2,3, James M Henderson1,2, Kiril Bidzhekov1

  • 1Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany (D.S., J.M.H., K.B., V.T., Y.J., F.M.F., M.A., X.B., R.T.A.M., Y.D., C.W.).

Circulation
|October 7, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
RNA-binding proteinsatherosclerosiscoronary artery diseasegenetics

More Related Videos

Quantification of Atherosclerosis in Mice06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

37.2K
Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.2K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2